Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 594Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
PHARMACOVIGILNCE PERSPECTIVES
Year : 2019  |  Volume : 10  |  Issue : 3  |  Page : 140-144

Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India


1 National Coordination Centre, Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, MoHFW, GoI, Ghaziabad, Uttar Pradesh; Research Scholar, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, Government of NCT, New Delhi, India
2 National Coordination Centre, Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, MoHFW, GoI, Ghaziabad, Uttar Pradesh, India

Correspondence Address:
Dr. Prasad Thota
National Coordination Centre, Pharmacovigilance Programme of India, Indian Pharmacopoeia Commission, MoHFW, GoI, Sector-23, Raj Nagar, Ghaziabad - 201 002, Uttar Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/picr.PICR_29_18

Rights and Permissions

Misuse of antimicrobials has become one of the grave concerns of public health. In last two decades, this has been largely contributing in the emergence of antimicrobial resistance (AMR) among all the pathogens. A 2013 report of Centres for Disease Control and Prevention, USA figured that at least 2 million people get an antibiotic-resistant infection every year and as many as 23,000 people lost their life. A multi-country survey in Southeast Asia region conducted by World Health Organization (WHO) in 2015, identified several gaps in knowledge and awareness about the optimal use of antimicrobials and AMR. Following this, the Ministry of Health and Family Welfare (MoHFW), Government of India, developed National Action Plan in the year 2017 to combat AMR. Pharmacovigilance Programme of India (PvPI) being a flagship programme of MoHFW holds the responsibility of ensuring safety of medicines used by India population and has recently identified AMR as one of the strategic priorities. This article intends to provide insights of the recent attempts and deliberate efforts made by PvPI in the containment of AMR in India and it also intends to sensitize healthcare fraternity on restricting AMR in public interest.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed150    
    Printed2    
    Emailed0    
    PDF Downloaded51    
    Comments [Add]    

Recommend this journal